Keyphrases
Triple-negative Breast Cancer
100%
Treatment Options
100%
Metastatic Breast Cancer
100%
Treatment Strategy
16%
Chemotherapy
16%
Gene Therapy
16%
Targeted Treatment
16%
Nanotechnology
16%
Hormonal Therapy
16%
Small Interfering RNA (siRNA)
16%
Quality of Life
16%
Combinatorial Approach
16%
Special Treatment
16%
Breast Cancer Treatment
16%
Treatment Type
16%
Estrogen Receptor
16%
Epidermal Growth Factor Receptor
16%
Treatment Therapy
16%
Human Epidermal Growth Factor Receptor 2 (HER2)
16%
Progesterone Receptor
16%
Biological Drugs
16%
Breast Carcinoma
16%
Predictive Biomarker
16%
Low Expression
16%
Targeted Gene
16%
Conventional Type
16%
Gifitinib
16%
Prognosis Biomarker
16%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Metastatic Breast Cancer
100%
Targeted Therapy
16%
Gene Therapy
16%
Biological Marker
16%
Hormone Therapy
16%
Quality of Life
16%
Cancer Therapy
16%
Receptor
16%
Immunotherapy
16%
Epidermal Growth Factor Receptor
16%
Estrogen Receptor
16%
Small Interfering RNA
16%
Progesterone Receptor
16%
Breast Carcinoma
16%
Epidermal Growth Factor Receptor 2
16%
Gamma Urogastrone
16%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Metastatic Breast Cancer
100%
Chemotherapy
16%
Biological Marker
16%
Hormone Cancer Therapy
16%
Receptor
16%
Epidermal Growth Factor Receptor
16%
Estrogen Receptor
16%
Progesterone Receptor
16%
Small Interfering RNA
16%
Immunotherapy
16%
Breast Carcinoma
16%
Epidermal Growth Factor Receptor 2
16%
Gamma Urogastrone
16%